Toxicology Mechanisms and Methods · 2019 · 69 citations · 28 references
Life SciencesCardiologyPharmacologyCellular PharmacologyChemotherapyMitochondrial BiologyAntioxidant DefenseMitochondrial DysfunctionMitochondrial PhysiologyMitochondrial ToxicityOxidative StressReactive Oxygen SpeciesCardiac Mitochondrial FunctionCell Viability AssaysDoxorubicin CardiotoxicityMitochondrial Function In CardiomyocytesMitochondrial Oxidative StressMitochondrial Toxicity MechanismsOxidative Stress InjuryPretreatment
Cardiotoxicity limits the clinical applications of doxorubicin (Dox), which mechanism might be excess generation of intracellular ROS. Quercetin (Que) is a flavonoid that possesses anti-oxidative activities, exerts myocardial protection. We hypothesized that the cardioprotection against Dox injury of Que involved 14-3-3γ, and mitochondria. To investigate the hypothesis, we treated primary cardiomyocytes with Dox and determined the effects of Que pretreatment with or without 14-3-3γ knockdown. We analyzed various cellular and molecular indexes. Our data showed that Que attenuated Dox-induced toxicity in cardiomyocytes by upregulating 14-3-3γ expression. Que pretreatment increased cell viability, SOD, catalase, and GPx activities, GSH levels, MMP and the GSH/GSSG ratio; decreased LDH and caspase-3 activities, MDA and ROS levels, mPTP opening and the percentage of apoptotic cells. However, Que's cardioprotection were attenuated by knocking down 14-3-3γ expression using pAD/14-3-3γ-shRNA. In conclusion, Que protects cardiomyocytes against Dox injury by suppressing oxidative stress and improving mitochondrial function via 14-3-3γ.
28
Reactive Oxygen Species (Ros-Induced) Ros Release
Dmitry B. Zorov, Charles R. Filburn, Lars‐Oliver Klotz et al. · The Journal of Experimental Medicine · 2000 · 1.4K citations · Full text
Quercetin attenuates doxorubicin cardiotoxicity by modulating <scp>B</scp> mi‐1 expression
Qinghua Dong, Long Chen, Qunwei Lu et al. · British Journal of Pharmacology · 2014 · 136 citations · Full text
Medicine, Oncology, Pharmacology +15